Earnings History Data for Kiora Pharmaceuticals (KPRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Kiora Pharmaceuticals
Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2024 | PM | KPRX | Kiora Pharmaceuticals | 10.00 | -0.81 | -0.90 | 0.00 | Kiora Pharmaceuticals GAAP EPS of -$0.81 misses by $0.05 [11/8/2024 7:26 AM] |
3.53 | -0.04 (-1.07%) |
3.54 | -0.03 (-0.79%) |
3.00 - 8.98 | 8,708 | 70,000 | 3,997 | ||
| 09-08-2024 | PM | KPRX | Kiora Pharmaceuticals | 10.00 | -0.53 | -0.95 | 0.00 | Kiora Pharmaceuticals GAAP EPS of -$0.53 beats by $0.33 [8/9/2024 7:47 AM] |
3.41 | 0.15 (4.60%) |
0.0 | 0.0 (0.00%) |
3.17 - 8.98 | 44,433 | 50,000 | 0 | ||
| 10-05-2024 | PM | KPRX | Kiora Pharmaceuticals | 13.00 | 0.38 | 0.62 | 0.00 | Kiora Pharmaceuticals GAAP EPS of $0.38, revenue of $16M [5/10/2024 7:23 AM] |
0.4861 | 0.0 (0.16%) |
0.54 | 0.05 (11.27%) |
0.45 - 2.65 | 163,746 | 130,000 | 60,304 | ||
| 09-11-2023 | PM | KPRX | Kiora Pharmaceuticals, Inc. | 4.87 | -0.89 | -0.30 | -4.35 | Kiora Pharmaceuticals reports Q3 results [11/9/2023 7:47 AM] |
0.6484 | 0.02 (3.33%) |
0.64 | 0.01 (1.99%) |
0.46 - 8.52 | 159,947 | 260,000 | 99,266 | ||
| 08-07-2022 | AH | KPRX | Kiora Pharmaceuticals | 6.00 | -0.27 | -0.23 | 0.00 | 0.4493 | -0.01 (-1.25%) |
0.46 | 0.0 (0.02%) |
0.35 - 6.43 | 50,028 | 200,000 | 1,005 | |||
|
|
||||||||||||||||||